Solid Biosciences (SLDB) Change in Account Payables (2017 - 2024)
Historic Change in Account Payables for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $815000.0.
- Solid Biosciences' Change in Account Payables rose 50820.9% to $815000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year increase of 38861.26%. This contributed to the annual value of $2.2 million for FY2024, which is 38861.26% up from last year.
- Latest data reveals that Solid Biosciences reported Change in Account Payables of $815000.0 as of Q4 2024, which was up 50820.9% from $918000.0 recorded in Q3 2024.
- Over the past 5 years, Solid Biosciences' Change in Account Payables peaked at $2.7 million during Q1 2023, and registered a low of -$5.9 million during Q4 2022.
- In the last 5 years, Solid Biosciences' Change in Account Payables had a median value of $210500.0 in 2022 and averaged -$301350.0.
- In the last 5 years, Solid Biosciences' Change in Account Payables crashed by 113614.04% in 2022 and then skyrocketed by 376619.72% in 2023.
- Solid Biosciences' Change in Account Payables (Quarter) stood at -$829000.0 in 2020, then skyrocketed by 168.76% to $570000.0 in 2021, then tumbled by 1136.14% to -$5.9 million in 2022, then surged by 102.27% to $134000.0 in 2023, then skyrocketed by 508.21% to $815000.0 in 2024.
- Its Change in Account Payables stands at $815000.0 for Q4 2024, versus $918000.0 for Q3 2024 and $1.1 million for Q2 2024.